Can You Take SPRAVATO With or Without an Oral Antidepressant?
Watch: SPRAVATO With or Without an Antidepressant: What Changed and How the Decision Is Made

From the TMS Therapy Centers Colorado video series. Educational only; not medical advice.
For several years, SPRAVATO came with a condition attached: it had to be taken alongside an oral antidepressant. Since 2025, that has changed for treatment-resistant depression in adults. This article explains the two paths, who might choose each, and how the decision is made. It comes from TMS Therapy Centers Colorado, a physician-led psychiatric clinic serving the Denver metro and all of Colorado.
What changed
For treatment-resistant depression in adults, esketamine is now FDA-approved both on its own and in combination with an oral antidepressant. The second indication, major depressive disorder with suicidal thoughts or actions, still requires the oral antidepressant.
If you are in crisis, call or text 988 (Suicide and Crisis Lifeline) or go to the nearest emergency room.
Which path makes sense
So which path makes sense for a given person? That is a decision for the evaluation, and a genuinely individual one. You can read an overview on our SPRAVATO page.
People who may prefer SPRAVATO alone
Some people arrive having spent years on medications that either did little or produced side effects they quietly endured: weight changes, emotional flatness, sexual side effects, or mental fog. For them, the prospect of a treatment that does not require staying on a daily pill can be the thing that makes SPRAVATO worth trying at all.
People who may keep the antidepressant
Others are on an antidepressant that helps partially, and the psychiatrist may see good reason to keep it in place while esketamine is added, since the two act through different pathways and may complement each other.
People for whom stopping is risky
There are also people in the middle of a medication change, or with a history that makes stopping a medication risky, where keeping the oral antidepressant is simply the safer choice.
What the evaluation weighs
The evaluation weighs all of this:
- Current medications
- What each one has done
- Side effect burden
- Relapse history
- The person's own preferences about what they are willing to take long term
Nobody should stop an antidepressant on their own in order to start SPRAVATO. Any change is planned with the prescriber.
What does not change
Nothing about the monotherapy option changes how SPRAVATO itself is given. The certified setting, the supervision, and the observation period are the same either way. A person still needs a ride home after each session, and driving waits until the next day.
How this fits with the early weeks
The first weeks of treatment follow the same pattern regardless of which path is chosen. You can read what induction looks like in our article on the first weeks of SPRAVATO. Symptom questionnaires are used at regular points to measure progress, so the decision to continue or adjust rests on something concrete.
Questions to ask at an evaluation
You might ask:
- Do I need to stay on my current antidepressant while receiving SPRAVATO?
- What are the advantages of using SPRAVATO alone for me?
- What would be the risks of stopping my current medication?
- How will we decide whether to adjust the plan?
- How does SPRAVATO compare with other options such as TMS?
TMS is FDA-cleared for major depressive disorder, and our TMS therapy page explains how it differs.
Questions people raise about going without a daily pill
People considering SPRAVATO alone often ask whether it is less effective, more risky, or harder to manage. The honest answer is that the decision is individual. Some people do well with the combination, and some are better served by monotherapy, and no rule fits everyone. What the psychiatrist wants to know is how you have responded to past medications, what you have tolerated, and what you would be willing to take long term. Your preferences are part of the clinical picture, not an afterthought.
When depression has not responded to medication
Many people considering this question have already tried several antidepressants. Our treatment-resistant depression page explains what that term means. For some, the option of a treatment that does not depend on staying on a daily pill is a major reason to consider SPRAVATO. For others, the oral antidepressant is a stable foundation and they would rather keep it in place. Both reasoning paths are legitimate.
Why one team handling both matters
At TMS Therapy Centers Colorado, medication management and the SPRAVATO decision are handled by the same physician-led team. That continuity means the person who knows your medication history is also the one planning your SPRAVATO course. There is no need to coordinate between separate offices, and changes can be made with the full picture in view.
A decision that can be revisited
The choice between the two paths is not necessarily permanent. A plan can be adjusted as a person responds, as side effects emerge, or as circumstances change. Starting with an oral antidepressant and later reconsidering, or the reverse, are both possible. The evaluation sets the starting point rather than locking in the outcome.
How care works at TMS Therapy Centers Colorado
TMS Therapy Centers Colorado was founded by William Kromka, MD, a board-certified psychiatrist. The evaluation is available in person or by private video anywhere in Colorado, and no referral is needed. Most major insurance plans are accepted, with benefits verified and prior authorization handled before treatment begins. To begin, call 720-500-7873.